Genomics-driven innovation as a catalyst for growth

Stephane Mattatia, Global Head of Derivatives Licensing and Thematic Indexes at MSCI, Caique Cardoso, ETF Specialist at Itau, Simon Barnett, Director of Life Sciences Research at ARK Invest share their views on how genomics innovation is creating opportunities for investors. These innovations encompass technological and scientific developments in DNA sequencing, gene editing, targeted therapeutics, bioinformatics, and agricultural biology.

Looking for a demo?
Request one now.

Thematic Investing

The top-down investment approach designed to capitalize on transformational trends such as disruptive technology as well as help investors understand and proactively manage how themes impact portfolios.